-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-2002
December 01, 2002 - detected 26 percent more cancers than PSA alone. 7 However, combining DRE and PSA also increases the … Sensitivity and specificity of PSA screening depend on the value used to define an abnormal PSA result … These include PSA density (the ratio of the PSA level to the volume of the prostate as measured by trans‐rectal … ultrasound (TRUS), PSA velocity (the rate at which the PSA increases over time), age‐ and race‐adjusted … reference ranges, and percentage of free PSA (the proportion of total PSA that is not bound to serum
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-2008
August 05, 2008 - The conventional PSA test cut-point of 4.0 μg/L misses some early cancer. … Variations of PSA screening have not yet been demonstrated to improve health outcomes. … age-adjusted PSA cut-points, free PSA, PSA density, PSA velocity, PSA slope, and PSA doubling time, have … over time (for example, measurements of PSA velocity, PSA slope, or PSA doubling time). … Prostate-specific antigen (PSA) best practice policy.
-
www.uspreventiveservicestaskforce.org/Home/GetFileByID/3795
May 01, 2018 - Risks for Men 55–69
The prostate-specific antigen (PSA) screening test is the most common method clinicians … The PSA test measures the amount of PSA, a type of protein, in the blood. … When a man has an elevated PSA level, it may be
caused by prostate cancer, but it could also be caused … (C grade)
Men Offered PSA-Based Screening
1,000 Of
Get a Positive Result
240
which may indicate … the trial.
***1.3 deaths are avoided per 1,000 men offered PSA-based screening.
-
www.uspreventiveservicestaskforce.org/Home/GetFileByToken/HV9RGq3wLyh6PyK4oxVtde
May 01, 2018 - Risks for Men 55–69
The prostate-specific antigen (PSA) screening test is the most common method clinicians … The PSA test measures the amount of PSA, a type of protein, in the blood. … When a man has an elevated PSA level, it may be
caused by prostate cancer, but it could also be caused … (C grade)
Men Offered PSA-Based Screening
1,000 Of
Get a Positive Result
240
which may indicate … the trial.
***1.3 deaths are avoided per 1,000 men offered PSA-based screening.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening
May 08, 2018 - 69 years
For men aged 55 to 69 years, the decision to undergo periodic prostate-specific antigen (PSA … C
Men 70 years and older
The USPSTF recommends against PSA-based screening for prostate cancer … Overall, 34% of invited men received a valid PSA screening test. … The false-positive rate for the PSA test depends on the PSA threshold used. … trial and men in the usual care group received 3 PSA tests. 26 This high PSA testing rate in the control
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zYdjLaTCTBVUwgJTnzpVXr
May 08, 2018 - EVIDENCE REVIEW The USPSTF reviewed the evidence on the benefits and harms of
PSA-based screening for … The reviews also examined the benefits
and harms of PSA-based screening in patient subpopulations at … Overall, 34% of invited men received a valid PSA
screening test. … The false-positive rate for the PSA test depends on the
PSA threshold used. … trial and
men in the usual care group received 3 PSA tests.26 This high PSA
testing rate in the control
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/prostate-cancer-screening
May 08, 2018 - Estimated Effects After 13 Years of Inviting Men Aged 55 to 69 Years in the United States to PSA-Based … USPSTF Assessment
PSA-based screening for prostate cancer has both potential benefits and harms. … Overall, 34% of invited men received a valid PSA screening test. … The false-positive rate for the PSA test depends on the PSA threshold used. … trial and men in the usual care group received 3 PSA tests. 26 This high PSA testing rate in the control
-
meps.ahrq.gov/data_files/publications/st233/stat233.pdf
January 01, 2009 - Food and Drug Administration (FDA) has approved
the prostate-specific antigen (PSA) test along with … Currently there is no consensus on the appropriate use of the PSA
test for early detection of prostate … Furthermore the USPSTF suggests that men
younger than 75 discuss the benefits and harms of the PSA test … However, less than half (44.2 percent) of men in the United States
ages 50 to 64 received a PSA test … Men aged 65 to 74 were more likely to
have received a PSA test for prostate screening than men ages
-
meps.ahrq.gov/data_files/publications/st233/stat233.shtml
January 01, 2009 - 76.9 percent) of men ages 65 to 74 were reported to have been screened for prostate cancer with the PSA … Food and Drug Administration (FDA) has approved the prostate-specific antigen (PSA) test along with a … Currently there is no consensus on the appropriate use of the PSA test for early detection of prostate … However, less than half (44.2 percent) of men in the United States ages 50 to 64 received a PSA test … More than three-fourths (76.9 percent) of men ages 65 to 74 received a PSA test in the past two years
-
meps.ahrq.gov/data_files/publications/st233/draft/stat233.shtml
January 01, 2009 - 76.9 percent) of men ages 65 to 74 were reported to have been screened for prostate cancer with the PSA … Food and Drug Administration (FDA) has approved the prostate-specific antigen (PSA) test along with a … Currently there is no consensus on the appropriate use of the PSA test for early detection of prostate … However, less than half (44.2 percent) of men in the United States ages 50 to 64 received a PSA test … More than three-fourths (76.9 percent) of men ages 65 to 74 received a PSA test in the past two years
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-test/research-protocol
December 01, 2019 - values, decreased percent-free PSA levels, elevated PSA velocities, complexed PSA, or externally validated … values, decreased percent-free PSA levels, elevated PSA velocities, complexed PSA, or externally validated … PCA3 comparators
Total PSA
Percent free PSA
PSA velocity
Complexed PSA
Externally validated … , percent free PSA, PSA velocity, complexed PSA, externally validated nomograms)
KQ3: No PCA3 testing … , % free PSA, PSA velocity, complexed PSA, or externally validated nomograms) in predicting initial or
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTHBrY6VuqjoouJvUmtkr4
May 01, 2018 - Lowering the age to stop screening, lengthening the
intervals between PSA testing, and raising the PSA … Unlike the
MISCAN-PRO or SCANS models, the PSAPC model models PSA growth (i.e., generates a PSA
level … Updated screening patterns
indicate that fewer AA men received PSA testing (at least one PSA test) in … > 4.0 µg/L or PSA velocity >0.35 µg/L per year
†Annual (quinquennial if age <50 and PSA <1 µg/L)
‡ … PSA >2.5 µg/L or PSA velocity >0.35 µg/L per year
§Annual (biennial if PSA <2.5 µg/L)
║Bienniel (quinquennial
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
April 01, 2012 - Psoriatic Arthritis in Adults:
Update of a 2007 Report
Executive Summary
Background
Psoriatic arthritis (PsA … PsA has a highly variable
presentation, which generally involves
pain and inflammation in joints and … In the general
population, the prevalence of PsA is
estimated to be 0.3 percent to 1 percent. … Census, 520,000 people ages 18 or older in
the United States have PsA. … However the current
available evidence for PsA was limited.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
April 01, 2012 - Psoriatic Arthritis in Adults:
Update of a 2007 Report
Executive Summary
Background
Psoriatic arthritis (PsA … PsA has a highly variable
presentation, which generally involves
pain and inflammation in joints and … In the general
population, the prevalence of PsA is
estimated to be 0.3 percent to 1 percent. … Census, 520,000 people ages 18 or older in
the United States have PsA. … However the current
available evidence for PsA was limited.
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research-protocol
October 14, 2011 - values, decreased percent-free PSA levels, elevated PSA velocities, complexed PSA, or externally validated … values, decreased percent-free PSA levels, elevated PSA velocities, complexed PSA, or externally validated … PCA3 comparators
Total PSA
Percent free PSA
PSA velocity
Complexed PSA
Externally validated … , percent free PSA, PSA velocity, complexed PSA, externally validated nomograms)
KQ3: No PCA3 testing … , % free PSA, PSA velocity, complexed PSA, or externally validated nomograms) in predicting initial or
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
January 01, 2010 - in comparing results of screening with PCA3
with results of traditional prostate specific antigen (PSA … Transcription-mediated amplification of PCA3 and PSA mRNA in urine sample
b. … How does sensitivity and specificity vary by score (ratio of PCA3/PSA
mRMA) cut-off?
b. … How do these issues vary as a function of PSA result and biopsy status?
4. … Reduction in unnecessary initial biopsies resulting from false positive PSA
results
ii.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
January 01, 2010 - in comparing results of screening with PCA3
with results of traditional prostate specific antigen (PSA … Transcription-mediated amplification of PCA3 and PSA mRNA in urine sample
b. … How does sensitivity and specificity vary by score (ratio of PCA3/PSA
mRMA) cut-off?
b. … How do these issues vary as a function of PSA result and biopsy status?
4. … Reduction in unnecessary initial biopsies resulting from false positive PSA
results
ii.
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16813/prostate-cancer-models-overview/pdf
May 01, 2018 - Lowering the age to stop screening, lengthening the
intervals between PSA testing, and raising the PSA … Unlike the
MISCAN-PRO or SCANS models, the PSAPC model models PSA growth (i.e., generates a PSA
level … Updated screening patterns
indicate that fewer AA men received PSA testing (at least one PSA test) in … > 4.0 µg/L or PSA velocity >0.35 µg/L per year
†Annual (quinquennial if age <50 and PSA <1 µg/L)
‡ … PSA >2.5 µg/L or PSA velocity >0.35 µg/L per year
§Annual (biennial if PSA <2.5 µg/L)
║Bienniel (quinquennial
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zxXWqacXvfKPyQB9LCrZjX
August 01, 2008 - Variations of PSA screening, including the use of age-
adjusted PSA cut-points, free PSA, PSA density … , PSA ve-
locity, PSA slope, and PSA doubling time, have been pro-
posed to improve detection of “clinically … over time
(for example, measurements of PSA velocity, PSA slope, or
PSA doubling time). … The conventional PSA
test cut-point of 4.0
g/L m
isses som
e early cancer. … Prostate-specific antigen (PSA) best prac-
tice policy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-test_research-protocol.pdf
October 14, 2011 - values, decreased percent-free PSA
levels, elevated PSA velocities, complexed PSA, or externally validated … values, decreased percent-
free PSA levels, elevated PSA velocities, complexed PSA, or externally validated … PCA3 comparators
○ Total PSA
○ Percent free PSA
○ PSA velocity
○ Complexed PSA
○ Externally … , percent free PSA, PSA velocity,
complexed PSA, externally validated nomograms)
KQ3: No PCA3 testing … , % free PSA, PSA velocity, complexed PSA, or externally
validated nomograms) in predicting initial